SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹11.79 | ₹16.16 | ₹17.83 | ₹14.23 | ₹12.45 |
What is the latest Earnings Per Share (EPS) of SUVEN PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹11.79 |
| Mar2024 | ₹16.16 |
| Mar2023 | ₹17.83 |
| Mar2022 | ₹14.23 |
| Mar2021 | ₹12.45 |
How is Earnings Per Share (EPS) of SUVEN PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹11.79 | -27.04 | |
| Mar2024 | ₹16.16 | -9.37 | |
| Mar2023 | ₹17.83 | 25.30 | |
| Mar2022 | ₹14.23 | 14.30 | |
| Mar2021 | ₹12.45 | - | |
Compare Earnings Per Share (EPS) of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹11,772.6 Cr | -13.3% | -26.2% | -71.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -13.3% |
-26.2% |
-71.7% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses